Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Agnosia × Electroacupuncture × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6 Neoplasms 5 Pain 4 Vomiting 3 Sleep Initiation and Maintenance Disorders 3 Prostatic Neoplasms 3 Nausea 3 Polycystic Ovary Syndrome 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Head and Neck Neoplasms 2 Depression 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Anxiety Disorders 2 Acupuncture 2 Xerostomia 1 Urinary Incontinence, Stress 1 Urinary Incontinence 1 Testicular Neoplasms 1 Teratoma 1 Sarcoma, Ewing 1 Sarcoma 1 Salivary Gland Neoplasms 1 Radiation Injuries 1 Prostatic Hyperplasia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Ileus 1 Ovarian Neoplasms 1 Ovarian Germ Cell Cancer 1

Interventions

Bupivacaine 9 Ketamine 8 Dexmedetomidine 7 Ropivacaine 6 Fentanyl 6 Anesthesia, General 6 Analgesics, Opioid 6 Acetaminophen 6 Morphine 5 Lidocaine 5 Acupuncture Therapy 5 Tramadol 4 Sodium Chloride 4 Pregabalin 4 Ethanol 4 Anesthesia, Local 4 parecoxib 3 Saline Solution 3 Radiofrequency Ablation 3 Propofol 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 Analgesia, Epidural 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 Transcutaneous Electric Nerve Stimulation 2 Surveys and Questionnaires 2 Oxycodone 2 Magnesium Sulfate 2 Levobupivacaine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04917796 2026-01-30

ACT

Dana-Farber Cancer Institute

Phase NA Active not recruiting

Neuropathy, Painful, Agnosia, Neuralgia, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡